These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9475670

  • 1. Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men.
    Johansson JO, Egberg N, Asplund-Carlson A, Carlson LA.
    J Cardiovasc Risk; 1997 Jun; 4(3):165-71. PubMed ID: 9475670
    [Abstract] [Full Text] [Related]

  • 2. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 3. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct 01; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

  • 4. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Oct 01; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels.
    Martin-Jadraque R, Tato F, Mostaza JM, Vega GL, Grundy SM.
    Arch Intern Med; 1996 May 27; 156(10):1081-8. PubMed ID: 8638995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 27; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia.
    Bai H, Liu BW, Deng ZY, Shen T, Fang DZ, Zhao YH, Liu Y.
    Free Radic Biol Med; 2006 May 15; 40(10):1796-803. PubMed ID: 16678017
    [Abstract] [Full Text] [Related]

  • 11. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
    Hsu HC, Lee YT, Yeh HT, Chen MF.
    J Lab Clin Med; 2001 Jun 15; 137(6):414-21. PubMed ID: 11385362
    [Abstract] [Full Text] [Related]

  • 12. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct 15; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
    Vega GL, Grundy SM.
    Arch Intern Med; 1994 Jan 10; 154(1):73-82. PubMed ID: 8267492
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T.
    J Lab Clin Med; 1993 Oct 10; 122(4):412-20. PubMed ID: 8228555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD.
    Am J Cardiol; 2005 Nov 01; 96(9):1266-72. PubMed ID: 16253595
    [Abstract] [Full Text] [Related]

  • 19. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 01; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 20. [Effect of fibrates on VLDL and LDL lipoprotein composition and parameters of their oxidation in hypertriglyceridemia].
    Zeman M, Zák A, Tvrzická E, Konárková M, Stípek S.
    Cas Lek Cesk; 2002 Apr 12; 141(7):211-6. PubMed ID: 12053756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.